IFN (IFN) Stock Price & Analysis
IFN (IFN) rose 0.19% to USD 10.8 as of June 10, 2026 at 05:09 UTC, according to Nexqual real-time market data.
IFN last closed at USD 10.78; the session ranged USD 10.72–10.95 on volume of 148,433 shares. Market capitalization is $460.64M, with a 52-week range of USD 10.72–16.6 (NYQ). Source: Nexqual, June 10, 2026 at 05:09 UTC.
Key Statistics (as of June 10, 2026 at 05:09 UTC)
| Price | USD 10.8 |
|---|---|
| Change | ▲ 0.19% (up) |
| Previous Close | USD 10.78 |
| Open | USD 10.83 |
| Day Range | USD 10.72 – 10.95 |
| 52-Week Range | USD 10.72 – 16.6 |
| Volume | 148,433 shares |
| Market Cap | $460.64M |
| Exchange | NYQ |
Technical Analysis (IFN)
Nexqual's technical model rates IFN "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:09 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 26.65 (oversold) |
| vs SMA50 | Below (USD 11.59) |
| MACD | -0.26 (negative) |
Analyst Ratings (IFN)
Wall Street analysts rate IFN "None", per Nexqual as of June 10, 2026 at 05:09 UTC.
| Consensus Rating | None |
|---|
Earnings (IFN)
Source: Nexqual, June 10, 2026 at 05:09 UTC.
Financials & Fundamentals (IFN)
| Total Revenue | $5.23M |
|---|---|
| Revenue Growth (YoY) | -16.00% |
| Gross Margin | +100.00% |
| Operating Margin | -103.29% |
| Profit Margin | +0.00% |
| ROE | -6.95% |
| Current Ratio | 0.44 |
| Total Cash | $9.91M |
| Total Debt | $0 |
Source: Nexqual, June 10, 2026 at 05:09 UTC.
Financial Health Score (IFN)
Nexqual rates IFN's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 05:09 UTC.
| Growth | Critical — Revenue -16% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $10M cash, no debt |
| Cash Flow | Mixed — No data |
| Efficiency | Critical — ROE -7%, ROA -0.3% |
Ownership (IFN)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +14.41% |
| Shares Outstanding | 42.65M |
| Short % of Float | +0.76% |
Source: Nexqual, June 10, 2026 at 05:09 UTC.
Leadership (IFN)
IFN is led by Gary Robert Marshall (age 64), Vice President, per Nexqual as of June 10, 2026 at 05:09 UTC.
| Vice President | Gary Robert Marshall (age 64) |
|---|
Major Backers & Investors (IFN)
Notable institutional backers of IFN include Morgan Stanley, Penserra Capital Management LLC, Amplify ETF Trust-Amplify CEF High Income ETF, according to Nexqual as of June 10, 2026 at 05:09 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 2.92% |
| Penserra Capital Management LLC | 2.61% |
| Amplify ETF Trust-Amplify CEF High Income ETF | 2.6% |
| Cetera Investment Advisers | 1.46% |
| City of London Investment Management Co. Limited | 1.36% |
| RIVERNORTH OPPORTUNITIES FUND INC.-Rivernorth Opportunities Fund Inc | 0.92% |
| Raymond James Financial, Inc. | 0.68% |
| LPL Financial LLC | 0.63% |
Source: Nexqual, June 10, 2026 at 05:09 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IIF | Morgan Stanley India Investment | USD 21.22 | ▲ 0.52% |
| IBN | ICICI Bank Limited | USD 26.29 | ▲ 1.31% |
| CEE | The Central and Eastern Europe | USD 20.89 | ▲ 1.06% |
| KF | Korea Fund, Inc. (The) New | USD 68.26 | ▲ 4.17% |
| RDY | Dr. Reddy's Laboratories Ltd | USD 13.37 | ▲ 0.98% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:09 UTC. This page is informational and not investment advice.